Author:
Chapman Andrew P.,Antoniw Pari,Spitali Mariangela,West Shauna,Stephens Sue,King David J.
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference16 articles.
1. Vaughan, T.J., Osbourn, J.K. & Tempest, P.R. Human antibodies by design. Nat. Biotechnol. 16, 535–539 (1998).
2. Dickman, S. Antibodies stage a comeback in cancer treatment. Science 280, 1196–1197 (1998).
3. Elliott, M.J. et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110 (1994).
4. Rankin, E.C.C. et al. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br. J. Rheumatol. 34, 334–342 (1995).
5. Bebbington, C.R. et al. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable marker. Bio/Technology. 10, 169–175 (1992).
Cited by
309 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献